President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...

The lines between fact, science, and uncertainty are increasingly blurred. Things once treated as dogma are being questioned.

The $22 billion energy drink industry is tapping into the aesthetics of health and wellness to reach new demographics and ...

Biotech investment firm RA Capital has laid off staff at its internal startup incubator, highlighting the instability among ...

Our most dangerous epidemic right now is not Covid, it is obesity, and we have the basic tools to fight it. Means is a ...

Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...

The emergence of Haemanthus, a company formed by Elizabeth Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and ...

OpenAI on Monday released a large dataset for evaluating how well large language models answer questions related to health ...

President Trump unveiled his plan to dramatically overhaul the way the U.S. pays for drugs. Pharma investors didn't seem to ...

In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much ...

House Republicans have unveiled their plan to reshape Medicaid, looking for cost savings as a way to offset planned tax cuts.